Sorry, unable to follow Tayo. Please try again.
Cell Therapy Development Leader with over 25 years of experience in hematology, transplantation, and cellular therapy. Passionate about improving access to cell therapy for all patients, significantly reducing the vein-to-vein time and empowering the local care team. My primary focus is on advancing the development of innovative platforms and effective treatments to achieve these goals for patients with hematologic malignancies, especially NHL, CLL and MM.
ViVoCMO LLC provides clinical development and strategic advisory consulting to emerging biotech, established programs, and organizations navigating the cellular therapy landscape.
• Lead the clinical development and execution of clinical strategies for multiple projects at AstraZeneca. • Oversee clinical aspects including clinical development, translational, and pediatric development strategies. • Ensure effective patient selection to optimize clinical outcomes. • Develop the TPP and ensure alignment with the disease area strategy.
Overseeing the strategic planning, execution and management of early and late-phase clinical studies in Non-Hodgkin Lymphoma with the ultimate goal of ensuring the successful advancement of our cell therapy therapeutic candidates to regulatory approval.
Investigator Brochures, Oncology and +16 skills